Concepedia

Carin A.T.C. Lunenburg

CA

11

Publications

923

Citations

11

H-Index

2017

Active since

Affiliations

Leiden University Medical Center(Current)

Oncode Institute

The Netherlands Cancer Institute

Erasmus MC Cancer Institute

Erasmus MC

Carin A.T.C. Lunenburg is an author at Leiden University Medical Center specializing in medicine, cancer research, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2017–2023

11

Publications

11

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 403 citations · Full text

, , +9

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis et al. · European Journal of Human Genetics · 2019 · 218 citations · Full text

A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · European Journal of Cancer · 2018 · 87 citations · Full text

, , +8

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study

Mirjam de With, Jonathan E. Knikman, Femke M. de Man et al. · Clinical Pharmacology & Therapeutics · 2022 · 54 citations · Full text

Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis

Jonathan E. Knikman, Tycho A. Wilting, Marta López‐Yurda et al. · Journal of Clinical Oncology · 2023 · 47 citations · Full text

Rows per page

1–5 of 11